Scientists hunt for genetic clues to diagnose mysterious brain diseases

NCT ID NCT05370079

Recruiting now Knowledge-focused Sponsor: Hospices Civils de Lyon Source: ClinicalTrials.gov ↗

First seen Jan 17, 2026 · Last updated May 23, 2026 · Updated 13 times

Summary

This study aims to collect blood and spinal fluid samples from 350 people with conditions like Parkinson's disease, ALS, glioblastoma, certain cancers, and rheumatoid arthritis. The goal is to find new genetic markers that could help doctors diagnose autoimmune encephalitis and paraneoplastic neurological syndromes more accurately. Participants provide samples but receive no direct treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PARKINSON'S DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; GLIOBLASTOMA; CANCER WITHOUT NEUROLOGICAL DISEASE; RHEUMATOID POLYARTHRITIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Hospices Civils de Lyon
RECRUITING

Bron, 69500, France

Contact

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

PARKINSON'S DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; GLIOBLASTOMA; CANCER WITHOUT NEUROLOGICAL DISEASE; RHEUMATOID POLYARTHRITIS